Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Coherence Neuro Australia Pty Limited
Baptist Health South Florida
Assistance Publique - Hôpitaux de Paris
Cancer Research UK
Swansea Bay University Health Board
University of Zurich
Assistance Publique - Hôpitaux de Paris
Fundación Canaria de Investigación Sanitaria
Universidade Federal de Pernambuco
Suzhou Maximum Bio-tech Co., Ltd.
Hospital del Rio Hortega
Catalysis SL
NaviFUS Corporation
University Health Network, Toronto
Sociedad de Lucha Contra el Cáncer del Ecuador